Tactile Systems Technology Inc Announces VA/DoD Distribution Deal

What Happened
On July 13, 2026, Tactile Systems Technology, Inc. announced an exclusive U.S. distribution agreement with ElastiMed, Inc. to bring MyoSleeve™ — a discreet, wearable, non‑pneumatic compression device for the lower leg — to patients served by the Department of Veterans Affairs (VA) and Department of Defense (DoD). Tactile made an upfront payment of $3.0 million to ElastiMed and committed to minimum purchase obligations plus marketing and sales promotion support. MyoSleeve is battery‑powered, tubing‑free, FDA 510(k) cleared, and indicated for chronic swelling conditions (chronic edema, lymphedema, venous insufficiency).

Key Details

• Agreement announced and disclosed on July 13, 2026 (press release filed as Exhibit 99.1).
• Tactile holds exclusive U.S. distribution rights for MyoSleeve within the VA and DoD systems.
• Upfront payment: $3.0 million to ElastiMed; additional minimum purchase and marketing commitments required.
• Product: MyoSleeve — wearable, electroactive polymer bands delivering intermittent compression; available by prescription; FDA 510(k) cleared.

Why It Matters
This deal expands Tactile’s product portfolio into a wearable, early‑stage compression option and gives the company exclusive access to the VA and DoD channels, which can be significant sources of volume and reimbursement. The agreement creates near‑term cash outflow (the $3M upfront) and binding purchase/marketing obligations, while offering potential revenue and market‑access benefits if adoption and payer reimbursement align. Investors should note the filing’s forward‑looking statements and the usual risks: reimbursement, supply, competition, and fulfillment of purchase commitments.